Journal of Gastroenterology
Fecha de publicación: 22 september 2018
Autores: Nagata, Y., Esaki, M., Moriyama, T. et al.
Background: Anti-tumor necrosis factor (TNF) therapy induces and maintains clinical remission in patients with Crohn’s disease (CD). However, the effect of anti-TNF therapy on the natural course of CD remains controversial. We aimed to investigate the effect of anti-TNF therapy on the initial intestinal surgery for CD.